4.50 -0.21 (-4.51%)
ZGEN
Stock Details
Last Trade:4.50 Change:-0.21 (-4.51%) Prev Close:4.71 Open: 4.66 Days Range:4.42 – 4.69 52 Week Range: 2.06 - 9.25 Volume:146695 P/E: N/AEPS:-1.35
View AllRecent Alerts 07/04/09
Recent Alert on 06/01/09 at 8:27am
ZymoGenetics (ZGEN) Reports Encouraging Phase 2 Results in Renal Cell Cancer for IL-21 with Nexavar
ZymoGenetics (ZGEN) Reports Encouraging Phase 2 Results in Renal Cell Cancer for IL-21 with Nexavar
ZymoGenetics, Inc. (NASDAQ: ZGEN) announced positive final results from a Phase 2 clinical trial in patients receiving 2nd or 3rd line therapy for advanced renal cell carcinoma with the combination of recombinant Interleukin 21 (IL-21) and... Read More
Recent Alert on 06/01/09 at 8:27am
ZymoGenetics (ZGEN) Reports Encouraging Phase 2 Results in Renal Cell Cancer for IL-21 with Nexavar
ZymoGenetics (ZGEN) Reports Encouraging Phase 2 Results in Renal Cell Cancer for IL-21 with Nexavar
Recent Alert on 05/13/09 at 8:45am
ZymoGenetics (ZGEN) Announces Promising Preliminary Results from Phase 2 Study of IL-21
ZymoGenetics (ZGEN) Announces Promising Preliminary Results from Phase 2 Study of IL-21
Recent Alert on 05/05/09 at 6:12pm
After-Hours Movers 5/5: FIG, ARM, DM, FVE, VOLC Higher; SHS, PLNR, HRS, VICR, PBI Lower
After-Hours Movers 5/5: FIG, ARM, DM, FVE, VOLC Higher; SHS, PLNR, HRS, VICR, PBI Lower
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available